• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

2

CATEGORIES

  • 9
  • 4
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

2
6
9
18

PUBLISHED

1
2
5
18

PRODUCT TYPE

16
2

Search "Acies Corporation" returned 18 results.

PRODUCT TITLE
(ACY)AEROCENTURY CORPORATION - Quantitative Valuation Report (ACY)AEROCENTURY CORPORATION - Quantitative Valuation Report - Product Thumbnail Image

(ACY)AEROCENTURY CORPORATION - Quantitative Valuation Report

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and useful report available. Our three models: Valuation Model, Forecast Model...

August 2014
AeroCentury Corporation,(ACY) Profile and Financials, plus Transportation Industry Trends Analysis, Operating Ratio and Financial Averages AeroCentury Corporation,(ACY) Profile and Financials, plus Transportation Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

AeroCentury Corporation,(ACY) Profile and Financials, plus Transportation Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for AeroCentury Corporation (ACY), plus vital industry benchmarks and extensive operating ratios, along with...

May 2013
FROM
Relapsed Multiple Myeloma - Pipeline Review, H2 2012 Relapsed Multiple Myeloma - Pipeline Review, H2 2012 - Product Thumbnail Image

Relapsed Multiple Myeloma - Pipeline Review, H2 2012

Relapsed Multiple Myeloma – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Relapsed Multiple Myeloma - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline....

September 2012
FROM

Ischemia - Pipeline Review, H2 2013

Ischemia - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Ischemia - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

July 2013
FROM

Relapsed Multiple Myeloma - Pipeline Review, H2 2013

Relapsed Multiple Myeloma - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Relapsed Multiple Myeloma - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

September 2013
FROM

Refractory Multiple Myeloma - Pipeline Review, H2 2013

'Refractory Multiple Myeloma - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline This report provides information on the therapeutic development for Refractory...

July 2013
FROM
Multiple Myeloma Therapeutics - Global Strategic Business Report Multiple Myeloma Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Multiple Myeloma Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for Multiple Myeloma Therapeutics in US$ Million The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World Annual estimates...

October 2011
FROM

Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2013

Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic...

July 2013
FROM

Mantle Cell Lymphoma - Pipeline Review, H2 2013

Mantle Cell Lymphoma - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Mantle Cell Lymphoma - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This...

July 2013
FROM
Ischemia - Pipeline Review, H1 2013 Ischemia - Pipeline Review, H1 2013 - Product Thumbnail Image

Ischemia - Pipeline Review, H1 2013

Ischemia – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Ischemia - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

February 2013
FROM
Blood Cancer - Pipeline Review, H2 2012 Blood Cancer - Pipeline Review, H2 2012 - Product Thumbnail Image

Blood Cancer - Pipeline Review, H2 2012

Blood Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Blood Cancer - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides...

December 2012
FROM
Refractory Multiple Myeloma - Pipeline Review, H2 2012 Refractory Multiple Myeloma - Pipeline Review, H2 2012 - Product Thumbnail Image

Refractory Multiple Myeloma - Pipeline Review, H2 2012

Refractory Multiple Myeloma – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Refractory Multiple Myeloma - Pipeline Review, H2 2012', provides an overview of the Refractory Multiple Myeloma...

July 2012
FROM
Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2012 Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2012 - Product Thumbnail Image

Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2012

Multiple Myeloma (Kahler's Disease) – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2012', provides an overview of the Multiple...

January 2012
FROM
Ischemia - Pipeline Review, H1 2012 Ischemia - Pipeline Review, H1 2012 - Product Thumbnail Image

Ischemia - Pipeline Review, H1 2012

Ischemia – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Ischemia - Pipeline Review, H1 2012', provides an overview of the Ischemia therapeutic pipeline. This report provides information...

January 2012
FROM
Ischemia - Pipeline Review, H2 2012 Ischemia - Pipeline Review, H2 2012 - Product Thumbnail Image

Ischemia - Pipeline Review, H2 2012

Ischemia – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Ischemia - Pipeline Review, H2 2012', provides an overview of the Ischemia therapeutic pipeline. This report provides information...

July 2012
FROM

T-Cell Lymphomas - Pipeline Review, H2 2013

T-Cell Lymphomas - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'T-Cell Lymphomas - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

October 2013
FROM

Thalassemia - Pipeline Review, H1 2014

Thalassemia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Thalassemia - Pipeline Review, H1 2014’, provides an overview of the Thalassemia’s therapeutic pipeline. This report provides...

June 2014
FROM

Depression - Pipeline Review, H1 2014

Depression - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Depression - Pipeline Review, H1 2014’, provides an overview of the Depression’s therapeutic pipeline. This report provides...

April 2014
FROM
Loading Indicator